logo-loader
viewPolarean Imaging PLC

Investor Symposium presentations available online

/**/ h1{margin-top:24.0pt;margin-right:0cm;margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;line-height:115%;font-size:14.0pt;font-family:"Calibri Light","sans-serif";color:#2F5496;font-weight:bold;}p{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";}ol{margin-bottom:0cm;}ul{margin-bottom:0cm;}link{ color: #0563C1 }visited{ color: #954F72 } .au{size:596.0pt 842.0pt;margin:42.55pt 42.55pt 42.55pt 42.55pt;}div.au{}p.bv{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin: 0cm; margin-bottom: .0001pt; text-align: center}span.bt{font-size:11.0pt;font-family:"Calibri","sans-serif"; color:black}span.bs{font-size:11.0pt; font-family:"Calibri","sans-serif";color:black}p.bw{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";font-weight: bold; margin: 0cm; margin-bottom: .0001pt; text-align: center}span.bp{font-size:11.0pt;font-family:"Calibri","sans-serif"; background:white}p.bx{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify;line-height:normal;text-autospace:none}span.bo{color:black}p.by{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify;line-height:normal} span.bm{color:black;background:white}p.bz{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; line-height: normal; margin-bottom: 0cm}table.ca{width:503.25pt;margin-left:-5.4pt;border-collapse:collapse}td.bj{width:228.6pt;padding:0cm 5.4pt 0cm 5.4pt}td.bh{width:253.05pt;padding:0cm 5.4pt 0cm 5.4pt}p.cb{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";line-height: normal; margin-bottom: 0cm; text-align: right}td.bf{width:315.0pt;padding:0cm 5.4pt 0cm 5.4pt}p.cc{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;line-height: normal}td.bd{width:166.65pt;padding:0cm 5.4pt 0cm 5.4pt}p.cd{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-div: italic; line-height: normal; margin-bottom: 0cm; text-align: right} td.bc{width:174.6pt;padding:0cm 5.4pt 0cm 5.4pt}td.bb{width:307.05pt;padding:0cm 5.4pt 0cm 5.4pt}td.ba{width:201.6pt;padding:0cm 5.4pt 0cm 5.4pt}td.az{width:280.05pt;padding:0cm 5.4pt 0cm 5.4pt}td.ay{border:none}p.ce{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; line-height: normal; margin-bottom: 0cm; text-align: justify}p.cf{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-div: italic; font-weight: bold; line-height: normal; margin-bottom: 0cm; margin-left: 144.0pt; margin-right: 197.55pt; margin-top: 0cm; text-align: center; text-autospace: none; text-indent: 36.0pt} /**/
RNS Number : 1674C
Polarean Imaging PLC
13 June 2019
 

Polarean Imaging Plc 

("Polarean" or the "Company")

 

Investor Symposium presentations available online

 

Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product for the magnetic resonance imaging (MRI) market, held an Investor Symposium for investors yesterday. The presentations are now available to view on the Company website:

 

http://www.polarean-ir.com/content/investors/videos.asp

 

Enquiries:

 

Polarean Imaging plc

www.polarean.com / www.polarean-ir.com

Richard Hullihen, Chief Executive Officer

Via Walbrook PR

Richard Morgan, Chairman




Walbrook PR

Tel: +44 (0)20 7933 8780 or [email protected]

Anna Dunphy / Paul McManus

Mob: +44 (0)7879 741 001 / +44 (0)7980 541 893

 

 

 

 

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
NRAEASKDFSXNEFF

Quick facts: Polarean Imaging PLC

Price: 23

Market: AIM
Market Cap: £26.32 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Polarean Imaging eagerly awaiting readouts from its key phase III clinical...

Polarean Imaging PLC's (LON:POLX) Richard Hullihen speaks to Proactive London's Andrew Scott following the news they've now completed patient enrolment for the phase III clinical trials of its MRI lung scan technology. He says the trials are now in the image and statistical analysis stage, a...

1 week, 4 days ago